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Abstract 
Misuse of codeine containing medicines is an emerging global public health concern. The majority of research 
has been conducted in developed countries (European Members States, Australia, United States).  This study 
aimed to gain an understanding of unique individual and collective experiences of trajectories of codeine misuse 
and dependence in South Africa. In-depth interviews were conducted with a purposive sample of adult codeine 
misusers and dependents (n=25). Narratives were analyzed using the Empirical Phenomenological 
Psychological five step method. Nine themes with 63 categories emerged, with two additional high levels of 
abstraction. Findings are illustrated participant profile and product preferences; motives for use; transitioning to 
misuse and dependence; pharmacy purchasing and alternative sourcing routes; effects and withdrawal 
experiences; help-seeking and treatment experiences; and strategies for prevention. The study underscores the 
need for continued support for enhanced patient awareness of risk of habit forming use and related health 
consequences and professional pharmacovigilance.  
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Misuse of and dependence on codeine containing medicines is an emerging global public health concern, given 
widespread availability of this weak opiate for the symptomatic relief of mild to moderate pain or cough 
(Lessenger & Feinberg, 2008; UNODC, 2011; Van Hout et al., 2014). Prescribed and non-prescribed opiate 
misuse trends appear driven by enhanced regulatory encouragement of patient self-care, prescribing trends and 
pharmacy retail availability (Collins & McAllister, 2006; Cooper, 2013a). Misuse is broadly defined as ‘the use 
of a medicine, with or without a doctor’s prescription, clearly outside of accepted medical practice or 
guidelines, for recreational purposes or in the framework of self-medication, in greater dosages or for longer 
periods than were prescribed, in which the risks and problems associated with use outweigh the benefits’ 
(Casati, Sedefov & Pfeiffer-Gerschel, 2012:229-230). 
Codeine or 3-methylmorphine is a methylated morphine derivative which occurs naturally in the poppy 
seed. Recommended adult daily oral doses ranges between 30-60mg every four hours and to a maximum of 
240mg  (Derry, Karlin, & Moore, 2013). Patient responses to codeine vary due to genetic variability in 
metabolism (Ingelman-Sundberg, 2007). Given codeine’s sedating and euphoric effect and development of 
tolerance within a relatively short timeframe on repeated use, products containing codeine carry identified 
abuse potential as reported in drug administration trials (Babalonis, Lofwall, Nuzzo, Siegel, & Walsh, 2013) 
and the case reporting of patient dependence (Sproule, Busto, Somer, Romach, & Sellers, 1999; Frei, Nielsen, 
Dobbin & Tobin, 2010; Nielsen, Cameron & Pahoki, 2010). Increased consumption of codeine containing 
medicines whether for therapeutic or non-therapeutic reasons results in neuro-adaptation and development of 
dependence symptomatology (Nielsen et al., 2010; McAvoy, Dobbin & Tobin, 2011; Reed et al., 2011). Two-
way and reciprocal displacement between prescribed and over the counter codeine misuse is reported in the 
literature (Cooper, 2013b). Withdrawal symptoms include cravings, preoccupation with seeking and taking 
codeine containing medicines, and lack of control of consumption patterns despite negative side effects 
(Romach, Sproule, Sellers, Somer, & Busto, 1999).  
Harms relating to misuse of and dependence on codeine containing medicines are well documented in 
clinical case reporting (Robinson, Robinson, McCarthy, & Cameron, 2010) and center on adverse health 
consequences relating to additives (such as ibuprofen, paracetamol or acetaminophen) contained in 
combination analgesic products. These include hypokalaemia, nephro-toxicity, gastrointestinal hemorrhage, 
acute hemorrhagic necrotizing pancreatitis and inflammatory bowel conditions (for an extensive review see 
Van Hout et al., 2014). Codeine misuse is also recognized as an iatrogenic cause of psychiatric co-morbidity 
(Manchia, Alda, & Calkin, 2013). Depression and dysphoric mood states are associated with long term use of 
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codeine containing medicines (Romach et al., 1999; Frei et al., 2010; Nielsen et al, 2010; McAvoy, Dobbin & 
Tobin, 2011).  
The majority of research on the misuse of and dependence on codeine containing medicines has been 
conducted in developed countries (United Kingdom (UK), Australia, France and the United States). Scoping 
reviews have underscored the heterogeneous nature of codeine misusers and those in treatment for dependence 
relating to age, gender, socio-economic status, presence of co-morbidity and substance disorders, and as distinct 
from other opiate using populations (Nielsen, Cameron & Lee, 2011; Van Hout et al.,  2014; Nielsen et al., 
2015). Prevalence of such diverse patterns of codeine misuse and dependence remain problematic in terms of 
surveillance and monitoring systems, with estimates based on treatment cases for codeine dependence  (Pates, 
McBride, Li, & Ramadan, 2002; Skurtviet, Faru, Borchgrevink, Handal, & Fredheim, 2011; Roussin, Bouyssi, 
Pouche, Pourcel, & Lapeyre-Mestre, 2013) . Low uptake for treatment is reportedly due to patient lack of 
recognition of problematic codeine use, and with individuals dependent on codeine generally perceiving 
themselves to be different from other drug users (Romach et al., 1999; Pates et al., 2002; Nielsen et al., 2010). 
Barriers to treatment uptake for codeine dependence centre on stigma and poor consideration of needs (Reed et 
al., 2011).  
In South Africa codeine containing medicines are currently available both over-the-counter (OTC) in 
pharmacies and as prescribed formulations. At the time of writing, the Medicines Control Council and the 
South African Department of Health are considering introducing regulations to reduce the amount of codeine in 
a single tablet to 10 mg and further tighten up on the sale of OTC medications containing codeine. Efforts to 
intervene and regulate the safe supply of codeine containing medicines have additionally centered on the 
“Codeine Care Project”, which uses a 2D barcode printed on the packs of all codeine containing medicines and 
a secure central database which monitors the national purchase of these medicines with national restrictions of 
sale set at 4g. This initiative incorporates additional customer informational and self-screening support in the 
form of a free phone app.  
Until recent times, national surveillance of problematic codeine consumption in South Africa was 
limited. Myers, Siegfried, and Parry (2003) in their study of 9 063 patients from 23 specialist substance abuse 
treatment centers in Cape Town, South Africa found that 1.25% of treatment admissions were using analgesics 
as a secondary substance of abuse, of which 40.4% reported the misuse of codeine-containing medication. The 
South African Community Epidemiology Network on Drug Use (SACENDU) initiated the measurement of 
codeine misuse in 2014. According to the latest SACENDU data collected (July to December 2014) at 
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specialist drug treatment centers, (Dada et al., 2015) 263 (of 10197) treatment admissions involved codeine 
misuse or dependence as a primary or secondary substance of abuse (2.6% of all admissions). Out of 263 
codeine misuse admissions, only 78 had codeine as their primary substance of abuse. In contrast to earlier 
studies reporting majority middle aged female representation (Myers et al., 2003), the majority of patients 
misusing or dependent on codeine in the SACENDU 2014 reporting period (Dada et al., 2015) were male with 
age ranging from 11 to 70 years. The highest proportion of patients was aged 20 to 29 (30.8%), followed by 30-
39 years (22.8%); and just over 18% under the age of 20 years. The majority of patients had a high school 
education or above and under half (45.2%) reported being currently employed. Nearly a third (34.4%) had 
received prior treatment.  
To date, qualitative investigations around user and patient experiences of codeine misuse and 
dependency have been conducted in the United Kingdom (Cooper, 2011, 2013b), Australia (Nielsen et al., 
2010; Nielsen et al., 2011; Nielsen, Cameron, & Pahoki, 2013), and with drug users interacting in online drug 
forums (Van Hout, 2015). To date, little qualitative research on the issue of misuse of prescribed and over the 
counter available codeine medicines has been conducted in the developing world. In this study we aimed to 
gain an understanding of unique individual and collective experiences of trajectories of codeine misuse and 
dependence in South Africa.  
 
Method 
Participants 
The study was undertaken as part of a large scale international collaborative research consortium 
(“CODEMISUSED”) on codeine use, misuse and dependence in Ireland, the UK and South Africa. A purposive 
sampling strategy was used to identify adult individuals in South African treatment centres with experience of 
codeine misuse and/or dependence. Exclusion criteria centred on the following: participants under 18 years of 
age; non-S.A residents; individuals reporting codeine use within accepted medical guidelines; individuals 
suffering from serious mental health problems and individuals with a known history of violence or aggressions.  
 
Recruitment was facilitated by the National Head Office of the South African Council for Alcoholism and Drug 
Dependence (SANCA) who have over 30 clinics and satellite clinics throughout South Africa. Referrals were 
requested from addiction treatment providers (gatekeepers) with restrictions to three to six eligible participants 
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per centre, and with balance across Gauteng, Western Cape and Kwa Zulu Natal. Additional recruitment of 
participants was supported by the 64 treatment centres that participate on the SACENDU surveillance system.  
 
Instruments 
An interview guide was developed based on the scoping review conducted by the CODEMISUSED consortium 
(Van Hout et al., 2014) and on extensive consultation between international partners. The guide centred on 
patient profile, use, misuse and dependence experiences, sourcing mechanisms, risk perceptions, awareness of 
harm, and  experiences of treatment. In order to assess dependence, participants completed the Severity of 
Dependence Screener (SDS) (Gossop et al., 1995) prior to interview. SDS is a 5-item questionnaire with scores 
of over five indicating dependent use of codeine containing medicines in the past 12 months.  
 
Procedure 
All interviews (n=25) with the exception of one were conducted face to face with the participants in a private 
area at the various treatment centres. Interviews were conducted by one researcher, with a note taker. All 
interviews were conducted in English, audio-taped with permission and lasted between 30 - 90 minutes. 
Participants were given a R100.00 shopping voucher in acknowledgment of their time. 
 
Ethical Considerations 
Ethical approval was granted by the Ethics Committee of the South African Medical Research Council (Protocol 
number EC021-11/2014). All researchers signed a Code of conduct, Data use and Confidentiality Agreement. 
All participants received an information and consent form, which was explained verbally by the investigator 
prior to interview. Face to face participants provided written consent prior to interview. In the case of the 
telephone interview, the interviewer and a witness signed the consent form. Assurances of confidentiality and 
anonymity were provided to all participants, along with permission to withdraw from the study if desired.  
 
Audio recordings were stored on a password protected encrypted hard drive, and destroyed following 
transcription.  Transcribes were coded for anonymity and stored on a password protected encrypted hard drive, 
following removal of any personal identifiers (Wilkinson & Thelwall, 2011). 
Page 6 of 27
http://mc.manuscriptcentral.com/qhr
Qualitative Health Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
‘Codeine is my Helper’: Misuse of and dependence on codeine containing medicines in South 
Africa 
7 
 
 
Data Analysis 
Transcribes were transferred in totality into a Word document with the final data set of 122,395 words. The 
Empirical Phenomenological Psychological (EPP) five step method (Karlsson, 1993) was utilized to analyse the 
data. This approach facilitates the interpretation of meaning and incremental understanding of lived phenomena 
(Husserl, 1970) such as the ‘life world’ experience of codeine use, misuse and dependence.  
 
Nine themes with 63 categories emerged from the analysis (Table 1). During the final step in the EPP 
analysis process, two additional higher levels of abstraction above the theme-level emerged and which centred 
firstly on the concept of misuse of codeine as coping mechanism to manage and pre-empt the occurrence of 
physical and psychological pain, in many cases relating to severe trauma and distress (for example, ‘Eventually 
there was not any pain, but I was scared of the pain in my mind’ (Male Participant) and ‘that would be my 
helper and I would run to my helper [codeine containing medicines]’, (Female Participant), and secondly the 
concept of the reinforcing nature of social circumstances in underpinning addiction (for example ‘I actually 
abused the codeine to supress my depression and to give that euphoric effect. I felt a lot of isolation, guilt and 
grief’ (Male Participant). All raw data were re-read with these two abstract concepts described by participants in 
distinct ways. 
 
Insert Table 1 here  
 
Results 
Participant Profile and Product Preferences 
Sixty percent (n=16) of the sample were male and 40% (n=10) were female. Participants ranged from 21 to 74 
years (mean age 43) with 67% (n=15) aged between 30-49 years. Sixty four percent (n=16) were unemployed 
although two of these were studying, one was disabled and a further two were retired. Twenty participants 
admitted to mis-using codeine within the last 12 months and the majority scored 10 or above (52% n= 13) on the 
SDS. Thirty-two percent reported codeine tablets as their primary drug of use, 20% reported codeine syrup as 
their primary drug of use and 12% reported consuming both.  
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Insert Table 2 about here  
In terms of tablet formulations containing codeine, Stilpane®, Syndol®, Myprodol® and Adcodol® 
were amongst the most common codeine containing medicines misused (Table 2) while a number of participants 
also had a history of using illicit drugs such as heroin, cannabis, cocaine and ecstasy. Some used codeine in 
combination with alcohol with a small number of female participants combining with diet pills.  
Thins? [Diet pills]. And that’s actually how I started [codeine], experiencing feeling good. 
(Female Participant). 
 
Some had previous experiences of misusing codeine based cough mixtures either on their own or 
with codeine containing tablets.  
 
Motives for Codeine Use 
Bio-psycho-social motives were identified as to why participants initially used or continued to misuse codeine 
containing medicines. Two male participants describe how they were socially exposed to codeine and the 
psychosocial reasons as to why they continued to take it: 
 
A friend of mine introduced it to me at a party. So I started taking it, to relax my mood. It is all 
exhausting, all the stress in my life. (Male Participant). 
 
Many participants reported taking codeine based medications to manage physical pain as a result of 
chronic conditions such as arthritis, migraine and severe headaches or to relieve pain (acute or chronic) 
following surgical interventions. One woman’s description typifies this trajectory of codeine use leading to 
misuse: 
 
I had a hysterectomy almost two years ago [and] that is when I started to use codeine, and also 
I got it through my sister. I had a problem with insomnia and then headaches because you are 
not sleeping. (Female Participant). 
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Many experienced various psychological issues in their lives, for example, depression, anxiety and 
stress related conditions and used codeine to deny or suppress their symptoms.  
I actually started using codeine as I was very depressed. I used it to lift up my moods, all the 
grief. (Male Participant). 
 
Social issues were viewed as both contributing to and a consequence of codeine use and misuse. Some 
reported that emotional and tangible support from family and friends sustained them through difficult times 
associated with their codeine use, misuse and dependence. Alternatively, poor social support, for example, lone 
parenting, marital and relationship disharmony, childhood experiences of a negative divorce process, 
unemployment and low self-esteem were reported as contributing stressful life factors that led to and sustained 
their codeine misuse and dependence. Consequences of misuse were loss of social support networks, for 
example, family, friends and work. A male participant summarises how codeine misuse and dependence led him 
to become: 
 
More and more isolated from life.  I didn’t care. I robbed myself through my own actions of 
human connectivity. I love my wife, I’ve always loved her, but I loved the drugs more at that 
point. Codeine was a real gateway, numbing yourself to the [social] world. (Male Participant). 
 
Transitioning from Codeine Use to Misuse and Dependence 
Initially, for many participants their use of codeine containing medicines was appropriate and used for 
legitimate reasons, prescribed or over the counter, to manage discrete episodes of pain. They were largely 
unaware of codeine’s addictive potential and the harms related to additives in Adcodol® or Myprodol®. Some 
were totally unaware of their actual addiction to codeine despite increase in their use; desire to continue to 
misuse and not being able to stop. Awareness of habit forming use and related tolerance was a gradual and 
subtle process with often a sudden realisation that they were consuming more than normal, sometimes 
recreationally, with their ‘bodies’ experiencing withdrawal and requiring more codeine containing medicines. 
Others commented on how: 
 
You can get very quickly addicted. (Female Participant).  
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Furthermore, one female health care worker describes how this pattern of use would ‘escalate’ 
especially as a result of on-going life events negatively impacting upon her to a position where:  
Things… go wrong …and I would run to my ‘helper’ [codeine containing medicine] and I 
would abuse whatever I took [beyond] the prescribed dose. (Female Participant). 
 
Daily use progressed within several weeks and many described how various stressors in their lives 
rapidly escalated their use of codeine containing medicines. Their daily use helped participants cope and 
tolerance grew quickly due to the medicines relaxing effects and pain management qualities. An increase in 
daily use,  
 
It creeps up on you particularly if you’ve got an addictive personality. (Male Participant).  
 
Others observed the pre-empting of physical pain and stated: 
It escalated from a prescribed dose that said take two to three times a day or two to eight 
hourly, I would just take six or eight at one time. It would be nothing to take two packs of 
Stilpane®. In the beginning it wasn’t a problem, but as things started to go wrong, that would 
be my helper and I would run to my helper [codeine containing medicines] (Female 
Participant). 
 
Use of codeine containing medicines was characterised by intense craving and the need to consume in 
order to function throughout the day. One participant observed that if the cravings could: 
 
just disappear, it would make it easier [to manage use]. (Male Participant).  
 
Process of Pharmacy Purchasing  
Many participants were of the view that over the counter codeine containing medicines were not drug[s] per se 
due to their free availability to purchase without any real regulations or protocols guiding their sale. Only a 
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minority (two) reported reading the product information leaflet and both were health professionals and aware of 
the addictive potential and related harms. 
Pharmacies were the primary source for purchasing codeine containing medicines. Most participants 
purchased over the counter with a few using scripts from their doctors. All described accessing multiple 
pharmacies in different locations and at various times in order to avoid suspicion. One male participant 
summarised a typical purchasing regime for many codeine misusers:  
 
I used to just walk in every week and ask for a hundred Adcodol® tablets. I used to use certain 
pharmacies in the area where I knew I could, like with the Stilpane® you obviously needed a 
script, I knew which pharmacies to go to without a script and I’d get it. (Male Participant).  
 
Participants described how it became a feature of their purchasing regime to identify the pharmacies 
within an area and to use intentionally each to build up their supply of codeine. Another male participant 
provides the following account:  
 
[When] I walk into a mall, I immediately pick up on the amount of pharmacies that are in the 
mall and it became a very engrained thing for me [to do]. If I drive around I can see there’s a 
pharmacy, there’s a pharmacy, there’s a pharmacy, so I would go around [pharmacy shopping] 
one day a week. (Male Participant). 
 
The male participant then proceeds to describe how he would purchase with relative ease and little or 
no questioning by pharmacy staff:  
 
Just drive around inside there picking up cough syrup bottles from large pharmacies, different 
pharmacies and the thing is they don’t really have a system to track it between pharmacies, 
[and] just give it out very, very, easily. (Male Participant ). 
 
Page 11 of 27
http://mc.manuscriptcentral.com/qhr
Qualitative Health Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
‘Codeine is my Helper’: Misuse of and dependence on codeine containing medicines in South 
Africa 
12 
 
However, he had to exercise caution as certain pharmacy chains had computer monitoring systems that 
were linked and this appeared to act as a deterrent. He describes how one major pharmacy chain questioned his 
recent purchasing history: 
 
XXXX [pharmacy chain] did notice at one time and asked me; ‘What happened? You bought 
from us like a week ago. It’s a 200ml bottle, it’s supposed to last like 2 months, not a week’, 
and so I just said ‘my bottle fell and broke’ and she gave me another one but said next time I’m 
going to need a prescription. (Male Participant). 
 
Being prepared to answer queries in a deceitful manner was a regular occurrence. Participants were 
manipulative when negotiating a script from their doctor or when purchasing codeine containing medicines. One 
male participant described this process and his awareness of how best to extract codeine from combination 
formulations (cold water filtration).  
 
I’d go and find another doctor, lie to them. It just became [part of] myself, a habitual liar, 
deceiving people, exaggerating. Exaggerating symptoms and manipulating the conversation. I 
always had an answer. I was pre-prepared before I went in. My response to a good result would 
be ‘thanks very much’ and walk out [of] the pharmacy wash it out [cold water extraction] and 
drink it. Some of the pharmacies are very responsible, [and] they ask you questions but the end 
result is always the same [you get your codeine]. (Male Participant). 
 
Some suggested that they are so many pharmacists in the cities and some are ‘corrupt… and this 
presents major problems’ (Male Participant) for South Africa and their regulation and monitoring of over the 
counter sales of codeine. It was felt that some ‘pharmacies will just give you prescription drugs with no script.’ 
(Female Participant). 
 
Diverse Alternative Sourcing Routes 
Alternative methods for sourcing codeine containing medicines centred on internet purchasing and diversion via 
prescriber, street and family routes. Travel to other jurisdictions with less stringent regulations around pharmacy 
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supply was reported, for example, to the Netherlands, UK and Ireland. Online access was an option for some 
and was favoured due to its accessibility with little or no questioning with regards to purchase transactions. 
  
I looked on the internet. I found that there are different kinds of opioids and that codeine was 
easily accessible. No one questioned me when I went to buy it. (Male Participant). 
Two participants described how their overseas travels created ideal opportunities for them to purchase 
over the counter codeine containing medicines. Others described purchasing on the ‘black market’ (Male 
Participant). Consulting several doctors was favoured by some especially when they were away from their home 
territory. They would report exaggerated ‘pain symptoms’ (Female Participant) to the doctors so as to yield 
scripts. Additionally, one health care worker described how her professional role and workplace facilitated her 
access to:  
 
All prescribed painkillers and I used to be able to get hold of them quite easily. I was working 
in places where I could get it. (Female Participant). 
 
The Codeine Effect  
Initial use of codeine containing medicines centred on physical pain. This use for the management of pain was 
accompanied by recognition of codeine’s pleasurable effects and it giving a ‘buzz’ (Male Participant), as well as 
its relief of some negative emotional symptoms related to stress, anxiety or depression. There is an ‘ultimate 
feeling of euphoria, relaxation and fulfil[ment] otherwise known as [the] ‘honeymoon phase… a sense of feeling 
good’ (Female Participant).  
 
You’re taking it to stop pain and then you start realising it’s taking the pain away but it’s also 
making me feel good. (Female Participant). 
 
Consumption of codeine containing medicines was a coping mechanism for many. One male participant 
described how he initially used cocaine but when he started misusing codeine his pain (physical and 
psychological) was subjectively better managed: 
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Eventually there was not any pain, but I was scared of the pain in my mind. The cocaine was an 
uplift. It makes you feel stronger, awake, alert.  But the moment I found the codeine, it would 
bring me down, calm me down, [I] don’t have to be present. All the things in the world that is 
horrible are just gone, all the physical pain would go away. (Male Participant). 
 
Another male participant stated how he used to feel depressed and that ‘the world is against you’ and 
how ‘codeine would make you feel better and [he would] go, go back [to how he normally felt]’ (Male 
Participant). Others reported taking codeine with alcohol and marijuana. The ‘high’ (Male Participant) 
associated with codeine was sustained longer when taken with marijuana, whilst combined with alcohol 
produced a ‘more relaxed [feeling] and… took… the edge off [you emotionally] (Male Participant). 
Furthermore, some who drank copious amounts of codeine based cough syrup as well as misusing codeine 
tablets experienced gross disturbances of perception leading to various types of visual and auditory 
‘hallucinations’ (Male Participant) coupled with suspicious or paranoid thought processes.  
 
Common side effects reported were gastrointestinal related, for example, dry mouth, loss of appetite 
and weight, vomiting, nausea, stomach cramps and constipation. Other common adverse side effects included 
headaches, dizziness, excessive perspiration, ‘goosebumps’, tachycardia and palpitations. Some participants 
were aware of the long term effects that codeine misuse could lead to, for example, liver and kidney damage 
caused by additives in combination products containing paracetamol (acetaminophen), and depression and 
anxiety relating to codeine itself. 
 
Withdrawal Experiences 
Experiences of unpleasant withdrawal symptoms such as pain (physical and psychological), fear, crying, self-
pity, irritability, anxiety, aggression, disturbed sleep patterns, perspiration, ‘the turkey skin and shivering’ (Male 
Participant) and ‘shocks down my body’ (Male Participant) were described. Such experiences often contributed 
to their continued use of codeine products. One woman describes her initial reason for use and her trajectory for 
sustained misuse as a consequence of withdrawal experiences: 
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It starts off with real pain. And then it [codeine] helps that pain because now you’re feeling 
good. You start noticing that every time taking it, I’m feeling good. Then you start taking it to 
feel good. But then another headache comes and you’re taking more. It’s a vicious cycle. 
Before you know it you’re withdrawing and you will walk into a chemist and buy it. (Female 
Participant). 
 
Two women describe their experiences in trying to stop taking codeine: 
It’s horrific; it’s terrible its wrong but you can’t stop yourself. It’s like you say today is the last 
day and maybe you skip one day but the next day as soon as that chemists opens you’re there. 
You can’t stop; it’s a non-stop train and I’m so scared.  (Female Participant). 
Some report resorting to other illicit drugs or engaging a hobby as a means for managing the cravings 
for codeine. As one young man states: 
 
I only smoked weed [cannabis] every now and then. It helps to calm me and helps with the 
relief of craving for codeine. That’s not going to help me going from one drug to the next. I just 
try and do a hobby.  I’m still battling. (Male Participant).   
 
While most participants described strong cravings and withdrawal effects, another young male reported 
how he successfully managed to reduce his misuse of codeine: 
 
Every time I tried to stop on my own I’d just taper down and just use fewer and fewer and 
fewer. There were still a little bit of withdrawal symptoms but it wasn’t as bad as what it could 
have been if I just like stopped immediately. (Male Participant). 
 
Help-seeking and Treatment Experiences 
Help-seeking and treatment for dependency involved detoxification, rehabilitation and counselling 
interventions. Many described their experiences of attending ‘rehab centres’ and the importance of dealing with 
underlying issues that impacted upon their addictions. Acceptance of being an addict and the impact this had 
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both psychologically and socially (family and work) motivated many to seek help. As one male participant 
describes: 
I just drowned in drugs [codeine and other drugs] and all this stuff is coming up again. I have 
relapsed so many times because I have never dealt with it. (Male Participant) 
 
Some had preference for psychological interventions, for instance seeing a psychologist to help them 
cope with their depression, anxiety or stressful situations. One young man felt that his ‘on-going use of 
[codeine] cough syrup to numb [his] depression’ was exhausting and negatively impacting upon his life; whilst 
others reported Suboxone® as being a very effective substitute in helping them ‘not to crave for the codeine’ 
(Male Participant). Some participants commented that an integrated pharmacy led detoxification treatment 
approach could complement existing treatment services or perhaps offer an alternative to mainstream drug 
treatment clinics.  
 
Strategies for Prevention 
While over the counter codeine containing medicines are regarded by many as effective medicines, a number of 
strategies were highlighted to promote more responsible use and minimise the risk of misuse and dependence. 
Areas highlighted were legislative changes and the up scheduling of codeine products; greater awareness and 
education of consumers by professionals that prescribe and dispense the medicines; enhanced implementation of 
strategies already in place, for example, the ‘Codeine Care’ project; greater enforcement of regulations 
governing the sales of codeine products and marketing strategies by manufacturers that clearly highlight to 
consumers that ‘codeine is highly addictive’ (Female Participant). The provision of information leaflets alone 
was regarded as ineffective as most people tend not to read them. A female participant makes an analogy that: 
 
[unlike] the cigarette companies…We don’t have any warnings. Just that small little paper 
[leaflet]. Who reads that; doctors tell us [but we] don’t really read it. Put the warning [on the 
box] that it’s addictive. (Female Participant). 
 
Discussion 
Page 16 of 27
http://mc.manuscriptcentral.com/qhr
Qualitative Health Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
‘Codeine is my Helper’: Misuse of and dependence on codeine containing medicines in South 
Africa 
17 
 
In this study we illustrated unique qualitative and contextual insights into codeine misuse and dependence in 
South Africa, and is the first study of its kind investigating this form of opioid pharmaceutical misuse and 
dependence within a developing country. The study builds on growing interest into codeine misuse and 
dependence pathways and trajectories as distinct from other forms of opiate dependence in the UK (Cooper, 
2011), and Australia (Nielsen et al., 2010). We recognise limitations of the study given the relatively small 
sample size, presence of history of prior drug taking histories and the effects of poly substance use behaviours. 
However ‘trustworthiness’ of the data gathered (Lincoln & Guba, 1985) in illustrating the codeine misuse and 
dependence phenomenon is enhanced by the verification of extensive similarities across the lived experiences 
and social contexts of these South African participants relating to codeine misuse as coping aid for physical pain 
and psychological pain, and dependence trajectories affected by social circumstance and isolation. Horizontal 
and vertical consistency was visible in the interpretation of the data, and supported by partial phenomenological 
psychological reduction  (Karlsson, 1993). 
Estimation and surveillance of misuse of codeine containing products is hampered by widespread and 
easy availability and the heterogeneous and hidden nature of misuse (Van Hout et al., 2014). Accessing of 
multiple pharmacies in a variety of locations and at different times, and to lesser extent, prescribers appeared 
common (Hamer, Spark, Wood, & Roberts, 2013). Efforts to secure multiple purchases appeared grounded in 
accessing many pharmacies, with little or no intervention from staff, existence of so called corrupt pharmacies, 
and free availability exempt from protocols or regulations guiding safe supply of non-prescription codeine-
containing medicines. Integrated pharmacy chain monitoring systems represented a deterrent. Diversion, ‘drug 
tourism’ and web sourcing offered alternative mechanisms to avoid detection.  Similar to SACENDU data 
(Dada et al., 2015), Stilpane®, Syndol®, Myprodol® and Adcodol® were commonly misused. Of interest is 
that in South Africa, misuse and dependence on codeine cough syrup (CCS) (Benylin®) was reported, in 
contrast with user preferences for codeine containing tablets elsewhere (Cooper, 2013b; Van Hout, 2015). 
Misuse and dependence on CCS is reported in the US southern states (Elwood, 1999; Peters et al., 2003; Peters 
et al., 2007; Agnich, Stogner, Miller, & Marcum, 2013) Poly pharming to potentiate the effect with illicit drugs, 
alcohol, and diet pills was reported.  
Similar to studies in Australia, France and the UK (Nielsen et al., 2010; Nielsen et al., 2011; Nielsen et 
al., 2013; Roussin et al., 2013; Cooper, 2013b) and SACENDU data in 2014 (Dada et al., 2015), daily use of 
codeine containing medicines for more than six months was common, and progressed within weeks of 
commencing use. Side effects of use were typically opioid related (constipating, stomach cramps, nausea, 
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emesis, headache). Awareness of both the medicines abuse and addiction potential, and harms related to additive 
(paracetamol or acetaminophen, ibuprofen) content in combination products was generally low. Also of note 
was whilst the recognition of the pleasurable effect was central, individuals’ lack of awareness of therapeutic 
and non-therapeutic forms of tolerance, escalation in frequency and dosage used, cravings and withdrawal 
symptoms mediated pathways toward dependence. Patient difficulties in self-identification of problems 
associated with their codeine use were common (Pates et al., 2002; Nielsen et al., 2010), and appeared grounded 
in the context of self-regulation vulnerabilities (Khantzian. 1997; Markou, Kosten & Koob, 1998; Nielsen et al., 
2010) such as the pre-empting of the occurrence of physical pain related to chronic conditions such as arthritis, 
migraine and severe headaches or to relieve pain post-surgical interventions, alleviation of emotional distress, 
self-medication of anxiety and social isolation; and for the numbing of trauma tied to life events.  This so called 
‘blurring’ of self-medication for therapeutic and legitimate reasons (pain) and misuse pathways toward 
iatrogenic dependence is described elsewhere (Sproule et al., 1999; Fishbain, Cole, Lewis,  Rosomoff,  & 
Rosomoff, 2008; Nielsen et al., 2011; Roussin et al., 2013) and in this study appeared fuelled by the presence of 
underlying psychiatric co-morbidity (depression, anxiety disorders), and the causal relationship with negative 
social and environmental circumstances of the codeine addict, and social consequences of addiction.  Self-
detoxification attempts as a result for the most part appeared unsuccessful. Treatment given these unique 
characteristics required psycho-social intervention, and opiate substitution modalities for optimal outcomes.  
 
Conclusion  
In this study a unique illustration of the codeine use, misuse and dependence phenomena in South Africa 
emerged. Whilst the South African ‘Codeine Care’ initiative represents an important and unique effort to 
counter misuse and inadvertent and intentional forms of dependence on codeine containing medicines, there 
remains a public health and medicines regulatory imperative in South Africa to consider up-scheduling, 
promotion of non-opioid analgesics, enhance patient awareness of abuse risk and dependence, and the related 
harms from excessive or long term use of combination products, ensure national pharmacy and medical 
surveillance and monitoring of misuse of medicines, and develop appropriate treatment protocols both within 
existing treatment services and as adjunct community based detoxification in pharmacies. Optimal treatment 
outcomes will require tapering of medication with long term and top–up cognitive behavioural based supports 
(Darker, Sweeney, Barry, Farrell, & Donnelly-Swift, 2015) given the interplay between the presence of physical 
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or emotional pain, maladaptive coping mechanisms, destruction of social connectivity for addicts, stigma and 
particular needs of this distinct treatment cohort  (Fishbain et al., 2008; Otto et al., 2009; Zahradnik et al., 2009; 
McAvoy, Dobbin & Tobin, 2011; Reed et al., 2011). 
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Tables  
Table 1 Themes and Categories  
Participant Profile and Product Preferences 
 
1. Stilpane®, Syndol®, Myprodol® and Adcodol® most common. 
2. Codeine cough mixtures included Benylin® . 
3. Some history of using illicit drugs such as heroin, cannabis, cocaine and 
ecstasy.  
4. Some use of codeine containing medicines in combination with alcohol. 
5. Minority female combining codeine containing medicines with diet pills.  
6. Some use of codeine based cough mixtures on their own or with codeine 
containing tablets.  
Motives for Codeine Use 
 
7. Bio-psycho-social motives identified as central to initial use and pathways 
toward misuse and dependence.  
8. Management of physical pain (arthritis, migraine, post surgery and severe 
headaches) 
9. Used to suppress psychological (depression, anxiety) and stress related 
conditions.  
10. Social issues contributed to and a consequence of codeine use and misuse.  
11. Emotional and tangible support from family and friends sustained patients 
through difficult times related to use, misuse and dependence.  
12. Poor social support contributed to stressful life factors underpinning initial 
and continued misuse and dependence.  
13. Consequences of misuse were loss of social support networks.  
Transitioning from Codeine Use to Misuse and Dependence 
 
14. Initial use was appropriate and used for legitimate therapeutic reasons.  
15. Lack of awareness of codeine’s addictive potential and the harms related to 
additives.  
16. Lack of awareness of personal actual addiction to codeine despite increase 
in their use; desire to continue to misuse and not being able to stop.  
17. Awareness of habit forming use and related tolerance was a gradual and 
subtle process underpinned by tolerance and withdrawal.  
18. Pattern of use would ‘escalate’ as a result of on-going life events. 
19. Daily use progressed within several weeks. 
20. Daily use helped support coping. 
21. Use for pre-empting of physical pain. 
22. Use characterised by intense craving and the need to consume in order to 
function throughout the day.  
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23. Without regular daily use sleep patterns were disrupted. 
Process of Pharmacy Purchasing  
 
24. View that over the counter codeine containing medicines were not drug[s] 
per se due to their free availability to purchase without any real regulations 
or protocols guiding their sale.  
25. Pharmacies were the primary source for purchasing codeine containing 
medicines.  
26. Majority purchasing over the counter with a few using scripts from their 
doctors.  
27. Accessing of multiple pharmacies in different locations and at various times 
in order to avoid suspicion.  
28. Identification of pharmacies within an area and use intentionally to build up 
supply.  
29. Purchasing with relative ease and little or no questioning by pharmacy staff:  
30. Computer monitoring systems appeared to act as deterrent.  
31. Being prepared to answer queries in a deceitful manner was a regular 
occurrence.  
32. Manipulative behaviour when negotiating a script from the doctor or when 
purchasing codeine containing medicines. 
33. Corruption in pharmacy sales viewed to underpin codeine misuse. 
Diverse Alternative Sourcing Routes 
 
34. Alternative methods for sourcing centred on internet purchasing and 
diversion via prescriber, street and family routes.  
35. Travel to other jurisdictions with less stringent regulations around pharmacy 
supply. 
36. Online access favoured due to its accessibility with little or no questioning 
with regards to purchase transactions.  
37. Purchasing on the ‘black market’ . 
38. Consulting several doctors when away from their home territory and 
facilitated by exaggerating pain symptoms.  
39. Health care work facilitated access. 
The Codeine Effect  
 
40. Initial use of codeine containing medicines centred on physical pain with 
recognition of codeine’s pleasurable effects, as well as its relief of some 
negative emotional symptoms related to stress, anxiety or depression.  
41. Consumption of codeine containing medicines was a coping mechanism. 
42. Use of codeine with alcohol and marijuana for optimal effect.  
43. Consumption of codeine based cough syrup as well as misusing codeine 
tablets caused gross disturbances of perception leading to various types 
visual and auditory coupled with suspicious or paranoid thought processes.  
44. Common side effects; dry mouth, loss of appetite and weight, vomiting, 
nausea, stomach cramps and constipation.  
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45. Common adverse effects; headaches, dizziness, excessive perspiration, 
‘goose bumps’, tachycardia and palpitations.  
46. Some awareness of long term effects such as liver and kidney damage, 
delirium and personality change. 
Withdrawal Experiences 
 
47. Experiences of unpleasant withdrawal symptoms; pain (physical and 
psychological), fear, crying, self-pity, irritability, anxiety, aggression, 
disturbed sleep patterns, perspiration, tremors and goose bumps. 
48. Such experiences often contributed to their continued use of codeine 
products.  
49. Difficulties were described in trying to cease use.  
50. Use of other illicit drugs (cannabis) or engaging a hobby as time diversion 
as a means for managing the cravings for codeine.  
51. One report of successful detoxification. 
Help-seeking and Treatment Experiences 
 
52. Help-seeking and treatment for dependency involved detoxification, 
rehabilitation and counselling interventions.  
53. Importance of dealing with underlying issues  
54. Acceptance of being an addict and the impact this had both psychologically 
and socially (family and work) motivated many to seek help.  
55. Some preference for psychological interventions to help cope with 
depression, anxiety or stressful situations.  
56. Some references to Suboxone® as very effective substitute. 
57. Integrated pharmacy led detoxification treatment approach can complement 
existing treatment services or offer an alternative to mainstream drug 
treatment clinics.  
Strategies for Prevention 
 
58. Codeine containing medicines regarded as effective 
Strategies highlighted to promote more responsible use and minimise the 
risk of misuse and dependence.  
59. Legislative changes and the up scheduling of codeine products;  
60. Greater awareness and education of consumers by professionals that 
prescribe and dispense the medicines;  
61. Enhanced implementation of strategies already in place, the ‘Codeine Care’ 
project;  
62. Greater enforcement of regulations governing the sales of codeine products 
and marketing strategies by manufacturers that clearly highlight to 
consumers addiction potential. 
63. Provision of information leaflets alone regarded as ineffective as most 
people tend not to read them.  
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Table 2 Codeine products most frequently reported as misused or causing dependence 
 
Product Quantity of 
codeine per 
tablet, capsule 
(mg) 
Other components and their 
quantities 
Stilpane® 8 Caffeine 32mg; paracetamol 
(acetaminophen) 320mg; 
meprobamate 150mg. 
Adcodo® 10 Caffeine 45mg; doxylamine 
5mg; paracetamol 
(acetaminophen) 450mg 
Myprodol® 10 Ibuprofen 200mg; 
paracetamol(acetaminophen)  
250mg 
Syndol® 10 Paracetamol (acetaminophen) 
450mg; doxylamine succinate 
5mg; caffeine 30mg 
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